These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9891904)

  • 21. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
    Cambazard F
    J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S20-7; discussion S28-9. PubMed ID: 9891905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topically administered clindamycin in the treatment of acne vulgaris and other dermatologic disorders.
    Rosen T; Waisman M
    Pharmacotherapy; 1981; 1(3):201-5. PubMed ID: 6242711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.
    Del Rosso JQ
    J Drugs Dermatol; 2007 Jun; 6(6):616-22. PubMed ID: 17668527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clindamycin/tretinoin: clindamycin phosphate/tretinoin gel.
    Drugs R D; 2005; 6(4):231-4. PubMed ID: 15991883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
    Chang AL; Alora-Palli M; Lima XT; Chang TC; Cheng C; Chung CM; Amir O; Kimball AB
    J Drugs Dermatol; 2012 Mar; 11(3):333-9. PubMed ID: 22395584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
    Dutil M
    Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical clindamycin in the management of acne vulgaris.
    Guay DR
    Expert Opin Pharmacother; 2007 Oct; 8(15):2625-64. PubMed ID: 17931096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clindamycin phosphate plus tretinoin 1.2%/0.025% gel (Ziana) for acne.
    Skinmed; 2007; 6(3):135-6. PubMed ID: 17478992
    [No Abstract]   [Full Text] [Related]  

  • 32. Topical treatment in acne: current status and future aspects.
    Gollnick HP; Krautheim A
    Dermatology; 2003; 206(1):29-36. PubMed ID: 12566803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris.
    Ochsendorf F
    J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 5():8-13. PubMed ID: 26059820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris.
    Leyden JJ; Krochmal L; Yaroshinsky A
    J Am Acad Dermatol; 2006 Jan; 54(1):73-81. PubMed ID: 16384759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are topical retinoids teratogenic?
    Veraldi S; Rossi LC; Barbareschi M
    G Ital Dermatol Venereol; 2016 Dec; 151(6):700-705. PubMed ID: 27598619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of clindamycin phosphate 1.2%/tretinoin 0.025% formulation for the treatment of acne vulgaris: pooled analysis of data from three randomised, double-blind, parallel-group, phase III studies.
    Dréno B; Bettoli V; Ochsendorf F; Layton AM; Perez M; Dakovic R; Gollnick H
    Eur J Dermatol; 2014; 24(2):201-9. PubMed ID: 24704684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical drug treatment in acne.
    Gollnick H; Schramm M
    Dermatology; 1998; 196(1):119-25. PubMed ID: 9557245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of sequential application of topical adapalene and clindamycin phosphate in the treatment of Japanese patients with acne vulgaris.
    Kubota Y; Munehiro A; Shirahige Y; Nakai K; Katsuura J; Moriue T; Murakami Y; Matsunaka H; Yoneda K
    J Dermatolog Treat; 2012 Feb; 23(1):37-45. PubMed ID: 21254867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
    Chassard D; Kanis R; Namour F; Evene E; Ntssikoussalabongui B; Schmitz V
    J Dermatolog Treat; 2006; 17(3):154-7. PubMed ID: 16854755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris.
    Jackson JM; Fu JJ; Almekinder JL
    J Drugs Dermatol; 2010 Feb; 9(2):131-6. PubMed ID: 20214175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.